tenidap has been researched along with indomethacin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carty, TJ; Moore, PF; Mylari, BL; Zembrowski, WJ | 1 |
| Arimura, A; Hori, Y; Inagaki, M; Jyoyama, H; Kakudo, S; Kato, M; Kawai, S; Kobayashi, M; Koizumi, K; Matsumoto, S; Ohno, K; Ono, T; Suzuki, R; Tsuri, T; Yamada, K; Yasui, K | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bhatti, R; Kaur, G; Kaur, S; Sharma, A; Singh, P | 1 |
| Blackburn, WD; Chatham, WW; Heck, LW; Loose, LD | 1 |
| Granger, DN; Panés, J; Russell, JM; Wallace, JL; Wolf, RE | 1 |
| Fraser, L; Larkin, SW; Showell, HJ; Warren, JB; Williams, TJ | 1 |
| Dawes, PT; Evans, E; Mattey, DL | 1 |
| Cloutier, JM; DiBattista, J; Loose, LD; Martel-Pelletier, J; McCollum, R; Pelletier, JP | 1 |
| Bliven, ML; Eskra, JD; Otterness, IG | 1 |
1 trial(s) available for tenidap and indomethacin
| Article | Year |
|---|---|
Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
Topics: Administration, Oral; Administration, Topical; Adult; Arachidonic Acid; Dose-Response Relationship, Drug; Erythema; Humans; Indoles; Indomethacin; Leukotriene B4; Male; Microcirculation; Naproxen; Oxindoles; Regional Blood Flow; Skin; Vasodilation | 1995 |
11 other study(ies) available for tenidap and indomethacin
| Article | Year |
|---|---|
1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Cell Line; Cyclooxygenase Inhibitors; Edema; Indicators and Reagents; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Molecular; Molecular Structure; Prostaglandin Antagonists; Pyrroles; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazines | 1990 |
Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Blood Platelets; Cyclic S-Oxides; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Female; Gastric Mucosa; Humans; Interleukin-1; Isoenzymes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Synovial Membrane; Thiazoles | 2000 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
TNF-α and IL-6 inhibitors: Conjugates of N-substituted indole and aminophenylmorpholin-3-one as anti-inflammatory agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Indoles; Interleukin-6; Mice; Molecular Docking Simulation; Molecular Structure; Morpholines; Nitric Oxide; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2017 |
Tenidap, in contrast to several available nonsteroidal antiinflammatory drugs, potently inhibits the release of activated neutrophil collagenase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Hypochlorous Acid; Ibuprofen; In Vitro Techniques; Indoles; Indomethacin; Microbial Collagenase; Naproxen; Neutrophils; Oxindoles; Peroxidase; Piroxicam; Reference Values; Superoxides | 1991 |
Effects of tenidap on leukocyte-endothelial cell adhesion in mesenteric venules.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Endothelium, Vascular; Indoles; Indomethacin; Leukocytes; Leukotriene Antagonists; Male; Oxindoles; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Venules | 1995 |
The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro.
Topics: Cell Division; Cells, Cultured; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Fibroblasts; Humans; Indoles; Indomethacin; Interleukin-1; Oxindoles; Rheumatic Diseases; Synovial Membrane | 1994 |
Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cartilage, Articular; Dexamethasone; Humans; Hydrocortisone; Indoles; Indomethacin; Metalloendopeptidases; Naproxen; Osteoarthritis; Oxindoles; Prostaglandins E; Protein Binding; Receptors, Interleukin-1 | 1993 |
Limitation of activity in an acute model of arthritis: effect of drug treatment.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Female; Indoles; Indomethacin; Injections, Intra-Articular; Mesocricetus; Motor Activity; Oxindoles; Piroxicam | 1997 |